Latest filing published 05 Jun 2026 for BioAtla, Inc., €52. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Eric Sievers on record concern BioAtla, Inc., in the capacity of senior executive. Over a trading history stretching from 14 June 2021 to 31 May 2026, the count stands at 49 filings.
Sales make up the whole of the open-market record (5 sales, €254k). The rest of the record consists of 43 share grants.
Most recently, on 5 June 2026, the filings show a share grant worth €453 in BioAtla, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations